skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Patterns of Failure After MammoSite Brachytherapy Partial Breast Irradiation: A Detailed Analysis

Journal Article · · International Journal of Radiation Oncology, Biology and Physics
 [1]; ; ;  [1]; ;  [2];  [1];  [3];  [4];  [1]
  1. Department of Radiation Oncology, Rush University Medical Center, Chicago, IL (United States)
  2. Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, Chicago, IL (United States)
  3. Department of General Surgery, Rush University Medical Center, Chicago, IL (United States)
  4. Department of Radiation Oncology, Creighton University Medical Center, Omaha, NE (United States)

Purpose: To report the results of a detailed analysis of treatment failures after MammoSite breast brachytherapy for partial breast irradiation from our single-institution experience. Methods and Materials: Between October 14, 2002 and October 23, 2006, 78 patients with early-stage breast cancer were treated with breast-conserving surgery and accelerated partial breast irradiation using the MammoSite brachytherapy applicator. We identified five treatment failures in the 70 patients with >6 months' follow-up. Pathologic data, breast imaging, and radiation treatment plans were reviewed. For in-breast failures more than 2 cm away from the original surgical bed, the doses delivered to the areas of recurrence by partial breast irradiation were calculated. Results: At a median follow-up time of 26.1 months, five treatment failures were identified. There were three in-breast failures more than 2 cm away from the original surgical bed, one failure directly adjacent to the original surgical bed, and one failure in the axilla with synchronous distant metastases. The crude failure rate was 7.1% (5 of 70), and the crude local failure rate was 5.7% (4 of 70). Estimated progression-free survival at 48 months was 89.8% (standard error 4.5%). Conclusions: Our case series of 70 patients with >6 months' follow-up and a median follow-up of 26 months is the largest single-institution report to date with detailed failure analysis associated with MammoSite brachytherapy. Our failure data emphasize the importance of patient selection when offering partial breast irradiation.

OSTI ID:
21036194
Journal Information:
International Journal of Radiation Oncology, Biology and Physics, Vol. 69, Issue 1; Other Information: DOI: 10.1016/j.ijrobp.2007.02.057; PII: S0360-3016(07)00549-4; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0360-3016
Country of Publication:
United States
Language:
English